Traduction de «produit opérationnel » (Français → Anglais) :

(38) In order to make this Directive fully operational and to keep up with technical, scientific and international developments in tobacco manufacture, consumption and regulation, the power to adopt acts in accordance with Article 290 of the Treaty on the Functioning of the European Union should be delegated to the Commission, in particular in respect of adopting and adapting maximum yields for emissions and their measurement methods, setting maximum levels for ingredients that increase toxicity, addictiveness or attractiveness , the use of health warnings, unique identifiers and security features in the labelling and packaging, defining ...[+++] key elements for contracts on data storage with independent third parties, reviewing certain exemptions granted to tobacco products other than cigarettes, roll-your-own tobacco and smokeless tobacco products and reviewing the nicotine levels for nicotine containing products .

1. Welcomes the Commission's initiative for better regulation of derivatives, and in particular OTC derivatives with a view to reducing the impact of the risks in the OTC derivatives markets for the stability of financial markets as a whole, and backs the calls for legal standardisation of derivatives contracts (inter alia through regulatory incentives in the Capital Requirements Directive (CRD) regarding operational risk), the use of trade repositories and centralised data storage, the use and strengthening of central clearing houses and the use of organised trading venues;

1. Welcomes the Commission’s initiative for better regulation of derivatives, and in particular OTC derivatives with a view to reducing the impact of the risks in the OTC derivatives markets for the stability of financial markets as a whole, and backs the calls for legal standardisation of derivatives contracts (inter alia through regulatory incentives in the Capital Requirements Directive (CRD) regarding operational risk), the use of trade repositories and centralised data storage, the use and strengthening of central clearing houses and the use of organised trading venues;

G. whereas the profit and loss account posted a fall of EUR 264 million from the previous year to EUR 588 million, whilst on the Charges side, Net losses on financial operations rose from EUR 15 million to EUR 73 million, Value adjustments (loans, advances, provisions) rose from EUR 9 million to EUR 62 million and Allocations to provision for the operating budget fell from EUR 274 million to EUR 26 million, and on the Income side, Interest received fell from EUR 420 million to EUR 345 million and Income relating to the ECSC operating ...[+++] budget fell from EUR 301 million to EUR 146 million,

While account has been taken of the specific needs of each region, it has proved possible for the priority measures in the operational programmes to concentrate on: - ensuring that both enterprises and infrastructures comply with the future Community standards on public and animal health, - restructuring and modernizing illaadapted enterprises in the sector while avoiding the risk of creating surplus capacities as much as possible, - promoting technical innovation and increasing added value, - adding value to aquaculture products.

The key deliverables of the initiative include an assessment of the TPP cost-recovery initiative as it relates to the Treasury Board cost-recovery policy, and the public and private benefits that have derived from it; a thorough assessment of the current cost-recovery initiative costing model used by the TPP, including a comparison of other regulatory regimes and justifications, identification of any gaps in the current cost-recovery initiative, and the contribution of fees to the delivery of an efficient service; an evaluation of whether the cost-recovery initiative has had an impact on the TPP's performance, taking into consideration previous performance commitments, other jurisdictions' experience, options for improving feedback and/or ...[+++] communication mechanisms for stakeholders to foster transparency and accountability, and constraints that might limit my program's ability to manage the cost-recovery initiative and thereby the efficient operations of its programs; an assessment of the direct, indirect, and cumulative impacts of the cost-recovery initiative on therapeutic products industries, on consumers and the health care system, and on the TPP itself, and the development of a rigorous methodology and relevant data sources for a follow-up assessment of the impact of planned fees on the medical devices regulation area; and finally, a systematic review of lessons learned from other jurisdictions and options for operational and/or organizational alternatives and/or modifications to improve the management of the TPP cost recovery initiative.